FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Initial back-of-the-envelope valuation on Rite Aid (NYSE: RAD) after today's Walgreen's deal pegs it at $3/share based on $600M EBITDA at a 8x multiple, according to sources.
Shares are currently trading down 22.7% to $3.04.
... MoreRite Aid (NYSE: RAD) reported Q1 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $8.17 billion.
Retail Pharmacy Segment revenues were $6.4 billion and decreased 4.9 percent compared to the prior year... More

